Reported Standalone quarterly numbers for Bharat Immunologicals and Biologicals Corporation are:Net Sales at Rs 25.36 crore in September 2020 up 213.02% from Rs. 8.10 crore in September 2019.
Quarterly Net Loss at Rs. 3.87 crore in September 2020 up 31.68% from Rs. 5.66 crore in September 2019.
EBITDA stands negative at Rs. 4.36 crore in September 2020 up 33.13% from Rs. 6.52 crore in September 2019.
Bharat Immuno shares closed at 53.85 on January 05, 2021 (BSE) and has given 211.27% returns over the last 6 months and 643.78% over the last 12 months.
| Bharat Immunologicals and Biologicals Corporation | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'20 | Jun'20 | Sep'19 | | Net Sales/Income from operations | 25.36 | 19.15 | 8.10 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 25.36 | 19.15 | 8.10 | | EXPENDITURE | | Consumption of Raw Materials | 19.82 | 21.41 | 44.53 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 3.43 | -7.61 | -34.29 | | Power & Fuel | -- | -- | -- | | Employees Cost | 3.47 | 1.58 | 2.55 | | Depreciation | 0.06 | 0.06 | 0.06 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 3.14 | 3.13 | 2.01 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -4.56 | 0.57 | -6.75 | | Other Income | 0.14 | -0.58 | 0.17 | | P/L Before Int., Excpt. Items & Tax | -4.42 | -0.01 | -6.58 | | Interest | 1.17 | 1.09 | 1.25 | | P/L Before Exceptional Items & Tax | -5.59 | -1.10 | -7.82 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -5.59 | -1.10 | -7.82 | | Tax | -1.72 | -0.32 | -2.16 | | P/L After Tax from Ordinary Activities | -3.87 | -0.78 | -5.66 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -3.87 | -0.78 | -5.66 | | Equity Share Capital | 43.18 | 43.18 | 43.18 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -0.90 | -0.18 | -1.28 | | Diluted EPS | -0.90 | -0.18 | -1.28 | | EPS After Extra Ordinary | | Basic EPS | -0.90 | -0.18 | -1.28 | | Diluted EPS | -0.90 | -0.18 | -1.28 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|